- Home
- WHD vs XENE Comparison
WHD vs XENE Comparison
Compare WHD & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHD
- XENE
- Stock Information
- Founded
- WHD 2011
- XENE 1996
- Country
- WHD United States
- XENE Canada
- Employees
- WHD N/A
- XENE N/A
- Industry
- WHD Metal Fabrications
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- WHD Industrials
- XENE Health Care
- Exchange
- WHD Nasdaq
- XENE Nasdaq
- Market Cap
- WHD 3.9B
- XENE 3.3B
- IPO Year
- WHD 2018
- XENE 2014
- Fundamental
- Price
- WHD $45.71
- XENE $34.26
- Analyst Decision
- WHD Hold
- XENE Strong Buy
- Analyst Count
- WHD 6
- XENE 7
- Target Price
- WHD $55.00
- XENE $57.00
- AVG Volume (30 Days)
- WHD 934.7K
- XENE 454.3K
- Earning Date
- WHD 04-30-2025
- XENE 05-08-2025
- Dividend Yield
- WHD 1.15%
- XENE N/A
- EPS Growth
- WHD 7.91
- XENE N/A
- EPS
- WHD 2.77
- XENE N/A
- Revenue
- WHD $1,129,814,000.00
- XENE N/A
- Revenue This Year
- WHD $3.73
- XENE N/A
- Revenue Next Year
- WHD $3.84
- XENE $826.46
- P/E Ratio
- WHD $16.78
- XENE N/A
- Revenue Growth
- WHD 3.00
- XENE N/A
- 52 Week Low
- WHD $43.27
- XENE $33.27
- 52 Week High
- WHD $70.01
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- WHD 34.38
- XENE 38.03
- Support Level
- WHD $45.49
- XENE $33.62
- Resistance Level
- WHD $48.05
- XENE $36.25
- Average True Range (ATR)
- WHD 1.37
- XENE 1.22
- MACD
- WHD 0.53
- XENE 0.02
- Stochastic Oscillator
- WHD 51.05
- XENE 22.28
About WHD Cactus Inc.
Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control , which generates key revenue and Spoolable Technologies.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.